Efficacy and safety of subcutaneous semaglutide once-daily versus placebo in patients with nonalcoholic steatohepatitis
Wed love to hear from you
First, the possibility of submitting false, underreported, inaccurate, incomplete, and delayed reports can hardly be solved, which may result in inevitable bias
The statement did not address questions about whether or not Eli Lilly would provide cost savings to patients in order to compete with generic semaglutide.
However, if injection site reactions persist, worsen, or are accompanied by signs of infection (increasing warmth, spreading redness, pus, or fever), contact your healthcare provider promptly
Price Red Flags Suspiciously low pricing (under $150 monthly) suggests potential quality or legitimacy issues